“Pseudoephedrine and Risk of Posterior Reversible Encephalopathy Syndrome (PRES): Case Report in an Adult Patient”. Ictus, vol. 5, no. 1, Mar. 2025, p. e08032505003, https://doi.org/10.5281/zenodo.15886568.